Cabot Dividend Investor Weekly Update
After pulling back over 8% from the high, the market is having trouble finding any traction. And the selling may not be over.
Read More
drug stock Archives
Cabot Stock of the Week 316
Technically, the market is now in an intermediate-term downtrend, which tells us that additional defensive measures would be prudent. In the very short term, however, I expect a bounce from today’s high-profile decline, so I’m mainly holding.
Read More
Cabot Dividend Investor Weekly Update
The raging bull market took a breather. The S&P 500 actually pulled back 7% from the high at the peak of the recent Labor Day selloff. But that seems to be over. The market has since regained some traction and appears to be an...
Read More
Cabot Stock of the Week 315
Overall, our market-timing indicators remain bullish, and thus the prescription for investing success is to maintain a diversified portfolio of healthy stocks.
Read More
Cabot Stock of the Week 314
Overall, our market-timing indicators remain bullish, and thus the prescription for investing success is to maintain a diversified portfolio of healthy stocks.
Read More
Cabot Dividend Investor Weekly Update
Labor Day marks the start of a new year of sorts and a rebirth of seriousness in the collective psyche. The other side of Labor Day is a new ballgame, when investors shake off the apathy of summer and refocus with intensity.
Read More
Cabot Stock of the Week 313
The bull market remains in full force, even as various signs (sentiment and charts) caution that a correction is increasingly likely.
Read More
Cabot Dividend Investor Weekly Update
These are the dog days of summer. It’s a rare time of year when a certain degree of slackery is not only tolerated, but expected. People tend to focus on enjoying the waning days of summer. More serious issues and considerations get postponed after...
Read More
Cabot Stock of the Week 312
The market’s strength has been very impressive, and our market-timing indicators continue to tell us that the market will be higher in the months ahead.
Read More
Cabot Dividend Investor Weekly Update
After a brief decline in early June, the market has resumed the uptrend that began on March 24th. It has been a spectacular 55% rally in less than five months.
Read More
Cabot Stock of the Week 311
The broad market continues to look very healthy, with good breadth that suggests the ultimate end of this bull run is still months away.
Read More
Cabot Stock of the Week 310
Despite a few cracks in growth stocks in the last couple trading days, the overall stock market continues to hum along, with the S&P 500 a mere 1% below all-time highs as of this writing.
Read More
Cabot Dividend Investor Weekly Update
The horrible second quarter is behind us and a rapidly recovering economy with a very accommodative Fed lies ahead. There are a lot of reasons for the rally and unless investors get scared straight the rally seems destined to continue.
Read More
Cabot Stock of the Week 309
The market’s main trend remains up, and thus our goal continues to be maintaining a full and diversified portfolio of high-potential stocks.
Read More
Cabot Dividend Investor Weekly Update
So far, earnings season hasn’t had that much of an impact on the overall market. I don’t think investors know quite what to make of this quarter. It’s bad. But everyone knows that going in.
Read More
Four Catalysts Driving Drug Stocks
Drug manufacturing is a $160 billion market, with $30 billion in profits. By 2020, sales are expected to top $170 billion. That bodes well for drug stocks.
Read More
Enter Your Log In Credentials
- Lost your password? Create New Password
- No account? Sign up